• Rape survivor sentenced to years in jail under El Salvador's extreme anti-abortion law
Law to force trusts to charge migrants
The UK government is to press ahead with plans to make it a legal requirement for NHS hospitals to charge foreign visitors and migrants upfront and in full for any non-urgent care received, as part of its crackdown on so called health tourism.
New regulations, to be laid out in parliament "in due course," will kick start the government's bid to recover m a year in costs of treatment of patients from countries inside and outside the European Economic Area by the end of -, a target that the National Audit O ce has said ministers will struggle to meet.
The plans, initially set to be implemented on April , seemed to have been shelved in the wake of the Brexit referendum and were not included in the Queen's speech last month. But the Department of Health for England has now con rmed that it is pressing ahead.
The government rst launched a programme in to tackle concerns that the NHS was "overly generous" to visitors from overseas. This included a new requirement for migrants and foreign visitors from outside the EEA to pay an additional % on the cost of treatment they received on the NHS and a policy to pay NHS hospitals % extra on the top of the cost of every procedure carried out on visitors from the EEA who have a European health insurance card (EHIC).
But progress has been slow. In a written answer disclosed in the House of Commons last week the government said that the UK had recovered m from EEA countries in -, leaving it some way short of the m a year that it had targeted as part of the overall m. Although the new legislation will not a ect migrants and visitors from other EEA countries who have their treatment costs covered through the EHIC, this may change in the future, depending on the terms of the UK's exit from the European Union.
Phillippa Hentsch, head of analysis at NHS Providers, said it was important that the measures did not compromise care or unduly burden trusts. "Rather than continue setting targets, we should prioritise helping trusts to learn from each other about what works," she added.
A spokesperson for the Department of Health for England said, "The government remains committed to ensuring overseas visitors and migrants not eligible for NHS funded care make a fair contribution. "
Medicolegal

Doctors are warned over image sharing
Doctors who share clinical information over file sharing apps and websites may be in breach of ethical obligations, the Medical Defence Union warned. It issued the warning after several members reported increasingly using apps to share clinical information. As well as gaining patients' consent before sharing images, doctors should ensure that images are taken on a dedicated clinical camera, quickly downloaded and then deleted from the camera, and transmitted and stored securely, the union advised.
Mental health
Extra funding is not getting through, say leaders
The government's commitment to improving mental health services in England is being undermined by a failure to channel funding to the front line, NHS leaders warned. NHS Providers, which represents NHS trusts, surveyed nearly two thirds of England's mental health trusts and found that rapidly rising demand, workforce shortages, and a failure of funding to get through to the front line were causing mental health services to deteriorate.
STPs
Councils feel shut out of talks to reshape services
Less than a quarter of local politicians are confident that plans to reshape local health and care services will succeed, the Local Government Association found. The association, which represents local authorities in England and Wales, also found that most councillors did not feel involved in shaping, commenting on, or approving the NHS's 44 sustainability and transformation partnerships (STPs), and they criticised the "unilateral topdown approach" of the NHS in some areas.
Brexit
Brexit poses risk to NHS finances, say trust leaders
More than half of NHS trusts (54%) warned that the UK's impending exit from the EU poses a medium or high risk to their organisation's financial health. Some 90% of NHS trust finance directors surveyed by the Healthcare Financial Management Association identified staff recruitment and retention as a key risk area. Most directors (68%) identified agency costs as a risk to their financial plans and a main area where they plan to make savings.
UK ministers call for EU cooperation on drugs
The health secretary, Jeremy Hunt, and the business secretary, Greg Clark (right), said that the UK will continue to cooperate with the EU on medicine testing after Brexit. In a letter to the Financial Times they outlined three principles for developing a post-Brexit drug regulatory system: that patients should not be disadvantaged, that innovators should be able to get their GPs' representatives in England have begun balloting general practices on the potential mass closure of patient lists in response to the ongoing crisis facing the profession.
The move comes after local medical committees, which represent GPs locally, passed a motion at their annual conference in May (left). This demanded that the BMA's General Practitioners Committee ballot GPs on whether they would be willing to collectively close their lists in response to the huge pressures facing general practice and the inadequate response of NHS England's rescue package.
In a letter sent to GPs on 10 July, Richard Vautrey, acting chair of the General Practitioners Committee, urged GPs to take part in the ballot by Thursday 10 August. He advised practices that collective list closures "would constitute industrial action" and have "significant implications" for GPs as independent contractors.
"GPC England needs a clear understanding of the views of all GP practices on this issue, and I would therefore urge you to ensure that your practice takes part in the ballot," he said.
A briefing document accompanying the letter explains that practices may cease the registration of new patients in two ways: by temporarily suspending new patient registrations, or by applying to the service commissioner for formal list closure. The guidance also explains that closing practice lists can be agreed only as a partnership.
Sexual health
Drug resistant gonorrhoea is rising, warns WHO
Data from 77 countries showed that gonorrhoea is increasingly resistant to treatment, as high income countries in particular report infections that are impossible to treat. WHO's global Gonococcal Antimicrobial Surveillance Programme published new data in PLoS Medicine showing that 66% of countries reported the emergence of strains resistant to the current last resort treatment-extended spectrum cephalosporins in the form of oral cefixime or injectable ceftriaxone.
Organ donation
Scotland plans move to opt-out system Scotland will introduce legislation aimed at increasing organ donation by moving to a "soft opt-out" system that will allow organs to be used in transplants without express permission. This is a reversal of the current situation, where people have to opt in by joining the donor card scheme. It follows a public consultation in which more than 80% of respondents supported the change.
Immunisation
Hepatitis B added to infant vaccination schedule
The hepatitis B vaccine is being introduced for newborns from the autumn, making the UK one of the last countries in Europe to introduce a universal hepatitis B vaccination programme for infants. All babies born on or after 1 August 2017 will be eligible for Infanrix hexa, which also protects against diphtheria, tetanus, pertussis, poliomyelitis, and disease caused by Haemophilus influenzae type b. The vaccine can also be used in children who have missed some primary immunisations.
Inquiry
Inquiry to look into blood transfusion deaths
The government is to hold a full inquiry into how thousands of people with haemophilia were infected with hepatitis C and HIV after blood transfusions in the 1970s and 1980s, before blood donors were routinely screened for the infections, Downing Street said. The health secretary, Jeremy Hunt, said that the inquiry would look into the deaths of 2400 people "to establish the causes of this appalling injustice," a spokesman said.
Infectious disease
Dengue fever kills hundreds in Sri Lanka
A deadly outbreak of dengue fever in Sri Lanka has killed at least 225 people and infected more than 76 000. Speaking to Sri Lanka's Daily News, the country's health minister, Rajitha Senaratne, warned that the death toll could increase as flood waters recede further. WHO has sent an emergency mission to the country, and the Sri Lankan government has deployed 450 troops to help combat the spread of the disease by aiding with rubbish collection and other sanitation issues. BUT NO ONE REALLY WANTS A RELATIONSHIP WITH A ROBOT Apparently they do. Last year 17% of 1002 adults questioned for the Nesta FutureFest survey said that they would be prepared to go on a date with a robot, and that increased to 26% for a robot that looked like a human. Phil, a 58 year old man who lives on Jersey, bought a robot for sex and now pushes it around in a wheelchair. Another man actually left his wife and family for one.
SO THEY'RE JUST FOR LONELY GEEKS?
A report from the Foundation for Responsible Robotics says that we could see sex robots being used to satisfy the sexual needs of disabled and elderly people and as part of therapy for people with issues such as erectile dysfunction, premature ejaculation, and anxiety about sex.
SO THERAPEUTIC?
To a point. Controversially, it has also been suggested that sex robots could be used to help prevent sex crimes such as violent assault, rape, and paedophilia, but most experts warn that this could increase the occurrence of these crimes, as well as the objectifi cation of women. There's already a childlike model, by Trottla, available in Japan; and the Roxxxy model, by TrueCompanion, has diff erent selectable personalities, one of which ("Frigid Farrah") will resist sexual advances.
WHAT'S TO BE DONE?
The Foundation for Responsible Robotics wants society to start looking at these issues and decide whether any regulation is needed, such as banning childlike robots, and whether such robots should be available on prescription.
Ingrid Torjesen, London 
Ingrid Torjesen, London "T he primary care home is a model of care developed by the National Association of Primary Care (NAPC). It's based on four key parameters: provision of care to a defined registered population of 30 000 to 50 000 patients, an integrated workforce, a focus on the personalisation of care, and aligned clinical and financial drivers.
"In general it's based around a GP registered population. In Larwood and Bawtry (in Nottinghamshire) we've developed a steering group so that all the organisations who look after our population have an equal say and input.
"Our three aims are staff support and wellbeing, better patient outcomes, and efficient ways of working. It's a non-contractual model so each organisation has kept its independence and its own contract, but we have created a way of working that has built a team approach to care.
"Every GP will tell you that they are frustrated by their inability to help people who have significant health needs but who also have needs driven by social factors, the wider determinants of health. We've now got our own community adviser for the primary care home who is able to see people quickly and signpost them to services in the area.
"Working with the voluntary sector has been one of the biggest changes in my career. We know that people's health is affected by issues such as employment, finances, and education. If we can tackle those things then we can significantly improve wellbeing and reduce ill health.
"People talk about 'GP at scale.' GP at scale isn't just about building bigger lists, it's also about working with other providers. So we're working at scale in a more integrated way than just becoming a bigger practice.
"The NAPC now has 175 primary care homes. This is a really big model, and if it sounds like common sense it's probably because it is." 
Steve Kell
The Bassetlaw GP says a new way of working has changed his practice Two psychiatric societies and a paediatrics association in Germany have condemned a new internet television series about a 17 year old girl who dies by suicide, saying that the series could trigger so called copycat suicides among troubled young viewers.
In addition, Germany's Professional Association of Paediatricians (BVKJ) has called for the "immediate cancellation" of the series. A member of the association's board, the paediatric cardiologist Josef Kahl, said that "adolescents contemplating suicide will probably be influenced in that direction by the series."
The 13 part series, called 13 Reasons Why, was produced in the US for Netflix and released around the world on 31 March. The title of the German language version of the series is Dead Girls Don't Lie (Tote Mädchen lügen nicht). The series has been so popular that Netflix announced that a second 13 part series will be produced for release in 2018.
A character in the series, Hannah Baker, leaves behind audiotapes detailing the 13 reasons why she would eventually commit suicide. The series shows events leading up to her contemplating suicide, including bullying, rape, drunk driving, and so called "slut shaming."
In 
German doctors condemn internet TV series depicting teenage suicide
The risk of sudden death in patients with symptomatic heart failure has halved over the past 20 years, a large study has reported. The authors suggest that the decrease is paralleled by greater use of evidence based drugs, such as angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers, and they question the benefit of implantable cardioverter defibrillators (ICDs) in most patients. The study analysed data from 40 195 patients with heart failure and reduced ejection fraction who were enrolled in any of 12 clinical trials from 1995 to 2014. The results, reported in the New England Journal of Medicine, showed that the rate of sudden death fell by 44% throughout this 20 year period (P=0.03).
Sudden death occurred in 2.4% of patients taking part in the earliest trials, but this decreased to just 1.0% in the most recent trial. Current guidance recommends that patients receive drug treatment for three months before considering use of an ICD. However, the researchers said that this may be too short a period and that the ejection fraction may continue to increase six to 12 months after starting drug treatment.
John McMurray, of the British Heart Foundation Glasgow Cardiovascular Research Centre at the University of Glasgow and who led the research, concluded, "Our study suggests that new efforts are needed to better identify the high risk subgroup of patients who would benefit most from ICD implantation." of patients taking part in the earliest trials, but this decreased to just 1.0% in the most recent trial filled bathtub and then slitting her wrists and arms lengthwise.
A joint statement issued by the German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy and the German Society for Psychiatry and Psychotherapy, Psychosomatics and Neurology said that "suicidal crises and even suicides" thought to be linked to the series have already been reported to the psychiatric societies.
The statement said that therapists, social workers, and teachers have reported that adolescents with affective disorders who had watched the series were being harmed.
The series failed to adhere to well recognised "international guidelines" on reporting and depicting suicide, the statement said, because it showed a graphic enactment of the suicide, implied that suicide was a "logical consequence" of the girl's suffering, the bmj | Mirza also admitted signing a statement in the form attesting that he had seen the patient's full medical records, when in fact he had not. He admitted that he had been dishonest in doing so and in initially denying his wrongdoing to NHS England and the General Medical Council after the Sun published its story.
The undercover reporter performed similar stings on two other London GPs. Mirza and one other were named by the paper, and video was released of the consultations. The third remains unidentified. The newspaper also found other agencies helping drivers to cheat on their topographical knowledge tests. The newspaper's coverage in October 2016 prompted a small demonstration in central London by drivers of licensed black cabs who said that Uber and minicab drivers were being certified when not competent or fit.
Deregistration sought
The coverage also drove Mirza to seek mentors as the GMC investigated him. One of these was Clare Gerada, a former chair of the Royal College of General Practitioners and medical director of the NHS Practitioner Health Programme. While two other senior doctors testified that Mirza had been fully frank with them about his dishonesty, Gerada's "carefully phrased" answers indicated that he had not told her he had made up the readings entered in the driver's medical declaration, said the tribunal's chair, Melissa Coutino.
Counsel for the GMC urged the panel to strike off Mirza, referring to an incident in Glasgow where a medically unfit driver caused a crash, resulting in the deaths of six bystanders. At one point during the video the "patient" tells Mirza, "When I get tired, my vision gets a bit blurry."
Mirza's defence lawyer argued that he had been fasting, had had a busy bank holiday weekend, covering for an absent partner, and was tired and thus less than usually conscientious.
Coutino said: "The tribunal recognised that you have apologised for your actions and that you engaged with your five mentors, attended groups in order to discuss your misconduct, and have undertaken remediation by attending courses and providing a reflective statement."
Erasure would be a "disproportionate" response to a two minute incident in an otherwise unblemished careers of two decades, she added. Mirza's case will be reviewed shortly before his suspension ends in 12 months. Governments in other UK nations should adopt Scotland's "less combative approach" to industrial relations to help breed happier staff who engage more in quality improvement, a report has concluded. The report, from the Nuffield Trust, said that the NHS in Scotland had benefited from a cooperative spirit and consistency in policy direction. This approach "may be one factor in creating the trust that supports the use of intrinsic motivation for quality improvement," it concluded.
Over half (57%) of anaesthetic trainees have experienced a crash or near miss when driving home after a night shift, a survey conducted by the Association of Anaesthetists of Great Britain and Ireland has found.
The study, published in Anaesthesia, outlined the findings of the survey, which received 2170 responses from UK anaesthetic trainees.
Most (84%) of the respondents said that they had felt too tired to drive home after a night shift, and 57% said that they had experienced a crash or near miss in doing so.
Respondents talked about falling asleep at the wheel and about being woken by rumble strips on the road, the paper said. "Adverse events were not only reported by motor vehicle users. There were also multiple reports of such events amongst walkers and cyclists," it said.
The survey found that only a third (32%) of trainees were aware of the existence of rest facilities in hospitals where they could sleep after a night shift, and just 17% had ever used such a room to sleep. The reasons given by trainees for not using rest facilities included "just wanting to get home" or the unsuitability and lack of accessibility of facilities.
Laura McClelland, a coauthor of the study, said, "We want rest facilities made available to people not only while they're working on their shift but also for an unlimited period between shifts, because a lot of the issues that arise post-shift stem from the fact that people don't know if facilities are available, they don't know where they are, how to access them." 
CLINICAL ACADEMIC WORKFORCE CONTINUES TO SHRINK
ROLES
The overall decline is partly the result of a 4.2% fall in reader and senior lecturer staff since 2015. Between 2000 and 2016 there was an overall increase in the number of professors, by 29.7%, but this was offset by a decrease of 32.9% in readers and senior lecturers and a 32% decline in lecturer grade staff.
FOUR NATIONS
The highest proportion of clinical academics is in England, home to 81% of all UK academic clinical staff, followed by Scotland (13%), Wales (4%), and Northern Ireland (2%). These numbers broadly match the distribution of student numbers at the UK's 34 publicly funded medical schools.
REGIONS
There is a concentration of clinical academic staff in London (31.6%), but this proportion has fallen by 5.5 percentage points since 2015. After London and Scotland, the biggest proportions of clinical academics are found in the North West (7.7%) and the West Midlands (7.1%). 
SPECIALTIES
Rest rooms at £70
A 10th of respondents also said that they had to pay for on-call rest rooms, the survey found. "We've seen prices of up to £70," McClelland said, "which, understandably, people don't want to pay. The calibre of the accommodation is not usually very high."
The survey also found that trainees were prevented from resting during their shifts by other members of staff. In free text comments, some respondents cited examples of nurses objecting to doctors resting on shift and, in some instances, intentionally disturbing them, the study said.
"Nursing staff are not meant to sleep on their shift. Many do, but it depends on the local policy, and they are far less supported and will often face disciplinary action if they are caught sleeping," McClelland said. "So, with that attitude towards nursing staff, it does put pressure on us. The expectation is sometimes that we [trainees] mustn't rest."
The Association of Anaesthetists of Great Britain and Ireland has established a "Fatigue Group" with the Group of Anaesthetists in Training and the Royal College of Anaesthetists, the paper said. It will look at establishing a "traffic light" grading system for rest facilities, at attitudes towards fatigue in hospitals, and at encouraging anaesthetists to advocate change.
McClelland said, "We've developed a set of standards which will be rolled out in the next couple of months. Even though it's not official guidance, it's the best that we have been able to come up with, and we hope that trusts will adopt these suggestions and work towards creating some official guidance in the future." Abi Rimmer, BMJ Careers Cite this as: BMJ 2017;358:j3328 A broad based training programme that was scrapped in 2015 was encouraging more trainees into general practice, including those who were not of a "generalist disposition," a review of the programme has concluded.
The Academy of Medical Royal Colleges launched the two year programme in 2013 to give trainees experience in general practice, psychiatry, paediatrics, and general medicine. In 2015, however, Health Education England decided to end recruitment to the scheme, although it is still available in Scotland and Wales.
A programme review, conducted by Cardiff University, found that most participants chose to enter GP training, attracting a broad range of trainees, the report noted, "not only those with a generalist disposition."
Recruiting enough trainees to fill all vacancies in GP training has been difficult in recent years, and in 2014 Health Education England began opening a third round of recruitment to help fill these vacancies.
The Cardiff researchers evaluated the characteristics of the trainees and divided them into three groups: "patients at the centre," "the working doctor," and "the open-minded specialist." Their report said, "It is interesting, and perhaps surprising, that the broad based training participants were spread across all three groups." It added, "Given the generalist drive of the scheme, we may have expected those on the broad based training programme to align themselves with the first group along with the majority of the GPs. This may suggest that the broad based training programme is not just attracting and developing trainees with a generalist focus but also those who have an open-minded specialist leaning and/or value a work-life balance."
Broad based trainees were also more self directed and demonstrated leadership and management skills, the report said, and were able to "take a more holistic approach to the care of their patients."
The authors wrote, "Educational supervisors suggested that these trainees were better equipped to deal with the more complex patients which they linked to their wider perspective. One commented: 'They were an answer to the future of the training in my view, or the future specialists.'" Alison Bullock, from the School of Social Sciences at Cardiff University, said that broad based training benefited patients "by giving doctors a wider knowledge and greater skills which are transportable across specialties." She added that it also gave trainees a "greater sense of self-determination over their career." "We are pleased that this training approach has been taken up in Wales and Scotland and hope that in time it will be re-adopted in England too," said Bullock. Abi Rimmer, BMJ Careers But the report also warned that an impending "intense financial squeeze" threatens to undermine the best aspects of the Scottish service.
Learning from Scotland's NHS is the first in a series of reports that will examine the health services in the four UK nations to assess their strengths and weaknesses and identify areas where they can learn from each other.
It highlighted that Scotland's unique system of quality improvement has delivered important changes through the Scottish Patient Safety Programme and equipped a cohort of staff with the skills to implement service change. The report concluded that the Scottish approach "provides possible alternatives for an English system with a tendency towards too many short-term, topdown initiatives that often fail to reach the front line."
Less positively, the report warned that the Scottish NHS faces a serious financial predicament, as some trusts have to make savings of 8% this year, higher than in other parts of the UK. Limited planning for the next few years and a polarised political context make it difficult to have an honest debate on the future, the report added.
Peter Bennie, chair of BMA Scotland, commented, "While this report rightly highlights some of the lessons that other parts of the UK could learn from Scotland's NHS, the major difficulties it highlights need to act as a wake-up call." Bryan Christie, Edinburgh 
Out of stock
Halima Lila, from Tanzania, Sophie, a youth campaigner, and Margaret Bolaji, from the Ugandan Adolescent Youth and Health Forum, join a queue of 214 women, each representing one million women and girls from developing countries, outside a mock "No Contraceptives" clinic in Soho, London, to highlight the plight of those across the world who don't have access to the contraceptives, advice, and services they need. The protest came on the opening day of the 2017 Family Planning Summit in London, aimed at accelerating access to modern contraception to women in 69 target countries by 2020.
Opening the summit, Melinda Gates, co-chair of the Bill and Melinda Gates Foundation, said that she was "deeply troubled" by President Donald Trump's proposal to stop US funding for international family planning initiatives.
Speaking on BBC Radio 4's Today news programme, Gates explained that complications in pregnancy and childbirth were the world's second cause of death among 15-19 year olds. "We have 1.2 billion adolescents coming of age in the developing world," she said. "They are having babies too young and too often. But offer them contraceptives, teach them about their bodies, and they take them up-and they space the births of their children and lift their families out of poverty. Contraception is one of greatest antipoverty innovations that we have." The biggest barrier to access was lack of supply, Gates added.
"We have nearly 220 million women asking for the tools which women use here in the UK. If we provide them, women will take them up. You have to allow local health agencies to deliver the services. They are coming up with their own funding as well."
Referring to Trump's proposals, she added, "I'm counting on Congress in the US to hold up funding on family planning. It's a longstanding bi-partisan issue. For a few dollars a year you can put a young girl on her path to self sufficiency." Rebecca Coombes, head of news and views, The BMJ About 40%-50% of patients with alcohol related liver disease will stop drinking after admission with cirrhosis; a community diagnosis also reduces hazardous drinking yes Liver disease is the second leading cause of potential years of working life lost in England and Wales ( ), a er ischaemic heart disease ( ). But although years lost from ischaemic heart disease have fallen by a factor of four since , those from liver disease years have increased threefold and are still increasing. The increase is in contrast to the trend in Mediterranean regions of Europe (France, Italy, Spain, Portugal, and Greece), which historically had the highest cirrhosis mortality but have seen signi cant declines. Reduction in alcohol consumption, hepatitis B vaccination, and reduced hepatitis C transmission have contributed to this decrease.
Liver disease will probably overtake heart disease to become the commonest cause of death in working age people in England and Wales in the next year or so. Only a third of patients admitted to hospital with liver disease will recover. There is no indication that things are improving, and there are at least two reasons for this.
Firstly, therapeutic options for the commonest causes of liver disease, alcohol and obesity, are limited. Secondly, liver disease develops without signs or symptoms, and many patients present with o en fatal complications of late stage cirrhosis. Data presented in a Lancet commission report in indicated that % of patients admitted as an emergency for liver disease in Southampton had not been previously referred to a liver or gastroenterology clinic, suggesting that the liver disease had not been detected beforehand.
Detection in primary care
Liver disease takes between and years to progress through brosis to cirrhosis, portal hypertension, liver failure, and liver cancer. It ought to be possible to detect patients with cirrhosis in primary care, but there diagnosis relies on tests for the enzyme alanine transaminase (ALT), and ALT concentrations are unrelated to stage of liver brosis; a recent systematic review found that % of patients with cirrhosis would not have been identi ed using standard liver tests.
The answer is to go upstream. A year upward trend in mortality from liver disease in the UK was reversed by the budget, which increased alcohol duty; however, the policy was abolished in , at a cost of . bn in lost duty, and since then liver deaths have been increasing again. Similarly, the solution for clinical hepatology is to go upstream; the technologies to identify early liver disease exist and are supported by the National Institute for Health and Care Excellence (NICE).
NICE guidelines
Recent guidelines on cirrhosis from NICE recommend that men and women drinking alcohol at potentially harmful levels-more than and units a week, respectively-be o ered transient elastography (Fibroscan) to exclude cirrhosis. This equates to about . million people in England and Wales. Reports suggest elastography is an e cient technique to exclude the diagnosis of cirrhosis whatever the cause. With a cut-o value of . kPa, chosen to obtain a % speci city, positive and negative predictive values for diagnosing cirrhosis are % and %, respectively.
Currently few GPs have access to this test so change is not going to happen overnight. However, because the lifetime cost of treating liver disease is between and , this approach is likely to be cost e ective.
One important question remains: if we detect patients with cirrhosis earlier, can we prevent progression of the disease? There are already highly e ective treatments for viral hepatitis and autoimmune liver disease, and numerous compounds are in advanced clinical trials for non-alcoholic fatty liver disease. About %-% of patients with alcohol related liver disease will stop drinking a er admission with cirrhosis, and evidence from a feasibility study shows that a community diagnosis also reduces hazardous drinking.
We will need properly controlled trials, and these studies are in preparation. However, the burden of liver disease is such that doctors cannot simply sit in their ivory towers waiting for patients with liver disease to come and nd them. Despite recent recommendations from NICE, insu cient evidence supports a screening programme for cirrhosis.
As physicians in busy liver units we see complications of liver disease every day; so, conceptually, cirrhosis seems an attractive target for screening to prevent an array of costly personal and societal events. The rising burden of liver disease in the UK, with a % rise in death rates since , sweetens this appeal. But conceptual simplicity must not be confused with validated justi cation.
For a successful screening programme the test used must be simple, cheap, and, most importantly, accurate. Early identi cation of disease is of bene t to patients only if there are e ective surveillance strategies or treatments that can be implemented as a result. Any screening intervention must also be cost e ective.
Evidence is lacking
A focus on the largest group at risk, the three million people in the UK estimated to be drinking alcohol hazardously, highlights where evidence to support screening is lacking.
The test proposed to screen for cirrhosistransient elastography-is not widely available and would require huge up-front investment to establish it in community settings. It has also been shown to perform poorly in people suspected to have alcohol related liver disease, with a false positive rate of %. Using this test to screen all hazardous drinkers would therefore lead to many people being incorrectly labelled as having cirrhosis.
For example, if one million hazardous drinkers were screened and the true prevalence of cirrhosis among them is %, about people would be falsely labelled as having cirrhosis-more than double the true number.
These people would subsequently be subjected to unnecessary surveillance interventions-including regular ultrasonography for the early diagnosis of liver cancer and upper gastrointestinal endoscopy for the detection of large oesophageal variceswithout any prospect of bene t and the risk of complications. In addition, concerns raised about the complications of cirrhosis, including the development of liver cancer, may cause psychosocial harms.
The most important action for a patient at risk of, or with, alcohol related liver disease is to reduce their alcohol consumption. This is recommended regardless of the result of any screening test for cirrhosis because it not only prevents progression of liver disease but protects the person from other harms related to hazardous alcohol consumption.
Existing brief alcohol interventions have been proved e ective in reducing alcohol consumption.
Whether they are enhanced by a screening test for cirrhosis is unknown. Without this evidence, it is more rational to identify people at risk of cirrhosis and implement interventions known to improve their health.
Surveillance interventions for patients with cirrhosis are associated with an uncertain bene t in terms of reducing mortality from liver disease. Surveillance for the development of liver cancer in particular is controversial since it is not supported by randomised controlled trials.
Opportunity costs
Finally, a screening programme for cirrhosis could worsen population health when healthcare resources are limited. Screening for cirrhosis in people who drink alcohol hazardously is probably not cost e ective at the per quality adjusted life year (QALY) threshold, modelling shows. The true cost e ectiveness would likely be even less because the modelling included unrealistically positive estimates of long term abstinence rates a er screening.
At that level of cost e ectiveness, and given the resource constraints in the NHS, implementation of screening for cirrhosis would inevitably lead to disinvestment in other, more e ective interventions, risking the overall health of the population.
Treating the most common liver diseases requires a risk factor based approachusing brief interventions to reduce alcohol consumption and addressing obesity and metabolic risk factors in people with nonalcoholic fatty liver disease-rather than a speci c diagnosis of cirrhosis. 
I
n the run up to the June general election there was the usual (unsolicited) advice from interest groups to the main parties on what they might like to do once in government. One suggestion made by several people was the need for an independent group to periodically make recommendations about future levels of health (and possibly social) care spending.
1 2 In the manner of headlines, this got abbreviated to an "OBR for health." But what does it mean? And why would such an exercise be worthwhile?
In some ways an OBR for health already exists-it's called, well, the OBR (the Office for Budgetary Responsibility). Set up by George Osborne in 2010, it provides "independent and authoritative analysis of the UK's public finances." 3 Part of its job is to produce regular projections of public spending (such as on healthcare), tax revenues, and other economic measures such as gross domestic product (GDP) up to decades ahead. In many ways this continues work that used to be done within the Treasury (fig 1) but is now conducted in a more transparent and, as the OBR advertise, independent manner. Similar organisations exist in other countries-for example, the Congressional Budget Office in the US also produces long term public spending projections (fig 2) . 4 The OBR's most recent projections for healthcare suggest that by 2066-67, UK health spending could be anything from 8.1% to 15.2% of GDP, from a starting point of 6.9% in 2020-21. 5 The variation in projections reflects uncertainty Nevertheless, the main aim of a Wanless-style future spending review was not just to set out the pressures on spending (like the policy neutral OBR approach) but to detail the costs of achieving the sorts of outcomes and user experience we might expect from the NHS in future. In doing so, Wanless believed, the necessary public and political debate about funding would be better informed, with argument more appropriately focused on the trade-offs and the values involved in future spending paths. Leaders in this arena are commonly referred to as chief clinical information officers (CCIOs). This is an emerging role in global health systems, including the NHS. Both the responsibilities of the role and the scope of practice vary across the system and remain defined by local context. However, wherever they work CCIOs need a wide range of competencies in research, data analytics, leadership,
EDITORIAL
Clinical leadership for a digital age
New cross-specialty officers need autonomy, authority, and a fully accredited career path
This new role must be seen as a genuine professional opportunity, alongside more traditional clinical professional roles. CCIOs must have enough authority to be able to have an effect across health and care systems.
Since 2009, the US has made substantial progress in this area. Respected universities and healthcare organisations have increased the number of informatics fellowships by more than 50%, expanded their health informatics capability, and substantially increased the number of senior leadership positions in informatics and digital transformation.
Dual careers
Over the past decade, the UK has seen structured careers develop in academic medicine following the Walport report, and clinicians can now train as academic clinical fellows. Leadership in informatics must now be given the same priority, with the same prospect for dual careers.
This emerging specialty requires rigorous and accredited training and professional recognition as recommended in Wachter's review and enshrined in the National Information Board's Personalised Health and Care 2020 programme. The launch of the NHS Digital Academy in September should help accelerate this progress, with accreditation and professional recognition coming from the newly formed Faculty of Clinical Informatics.
The academy will offer professionally recognised training, aiming to develop a cohort of 300 informatics leaders over the next few years. They will drive the digital agenda across the NHS, maximising the benefits of modern technology to improve patient outcomes and ensure sustainable and affordable health care well into the 21st century. and management, and a strong understanding of health informatics and the health and care system.
The NHS in England needs to place such people in authoritative positions with the autonomy to make strategic decisions and to develop and manage high performance teams.
Clinicians first
A CCIO or clinical informatics leader requires competencies in both information technology and leadership, but first and foremost they must be clinical professionals with front line experience of patient care.
The CCIOs will also need a portfolio of data analytical and research skills complementing their clinical skills. This will enable them to drive systematic learning across their organisations, so every member of the workforce routinely uses real time data and information to inform decisions.
To achieve all this, the CCIO will need to understand the importance of user centred design of technology platforms and understand the critical role of patients and carers in stimulating and fostering innovation throughout healthcare. Working with patients, carers, and the wider public will ensure that digital technology is embedded in each organisation's strategic and operational plan for delivering the triple aim of healthcarebetter patient outcomes, better patient experience, and affordability. 
CCIO
